Kooman & Associates’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,122
Closed -$219K 52
2025
Q4
$219K Sell
1,122
-157
-12% -$37.4K 0.06% 49
2025
Q3
$360K Sell
1,279
-103
-7% -$26.2K 0.11% 37
2025
Q2
$302K Buy
+1,382
New +$223K 0.1% 40
2025
Q1
Sell
-1,457
Closed -$243K 50
2024
Q4
$243K Sell
1,457
-9
-0.6% -$1.6K 0.09% 43
2024
Q3
$250K Sell
1,466
-92
-6% -$13.3K 0.09% 42
2024
Q2
$220K Buy
+1,558
New +$193K 0.09% 44

Other funds holding ORCL

Kooman & Associates's ORCL Position: Q1 2026 in Review

Kooman & Associates sold out of Oracle (ORCL) in Q1 2026, closing a stake of 1,122 shares — an estimated $219K sold.

Kooman & Associates first reported a position in ORCL in Q2 2024 and held it in 6 quarters. The position peaked at $360K in Q3 2025. 3,474 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Kooman & Associates reported no remaining Oracle position as of Q1 2026 after selling out during the quarter.
  • Kooman & Associates sold 1,122 Oracle shares in Q1 2026, an estimated $219K.
  • Kooman & Associates first reported a position in Oracle in Q2 2024 and held it in 6 quarters.
  • Kooman & Associates's Oracle position peaked at $360K in Q3 2025.
  • 3,474 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Kooman & Associates's 13F filing for Q1 2026, filed 21 Apr 2026.